The Department of Health and Human Services' deal with Moderna, which calls for up to 100 million doses of a potential COVID-19 vaccine, also includes the ability to purchase an additional 400 million doses.
DSN spoke with Ken Paulino, head of Vaxserve at Sanofi Pasteur, about the company’s capabilities in helping retail pharmacies manage their immunization efforts.
Industry organizations are signaling that pharmacy can play a critical role in actually administering the millions of COVID-19 vaccine doses needed to curb the pandemic.
GSK will supply more than 50 million doses of its influenza vaccines for the U.S. market during the 2020-2021 season, an increase from 46 million during the 2019-2020 influenza season.
The Department of Health and Human Services’ agreement with Pfizer for the production of 100 million doses of a COVID-19 vaccine allows the U.S. government to acquire an additional 500 million doses.
The National Association of Chain Drug Stores’ board of directors recently took the case of pharmacy's role in responding to COVID-19 to the Department of Health and Human Services assistant secretary for health, Adm. Brett Giroir.
